Janus Henderson Group PLC raised its position in Maximus, Inc. (NYSE:MMS) by 718.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 2,211,638 shares of the health services provider’s stock after purchasing an additional 1,941,521 shares during the period. Janus Henderson Group PLC owned about 3.41% of Maximus worth $138,515,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Acrospire Investment Management LLC grew its holdings in Maximus by 17.6% in the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock valued at $125,000 after purchasing an additional 300 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Maximus by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock valued at $148,000 after purchasing an additional 220 shares during the last quarter. First Bank & Trust grew its holdings in Maximus by 4.2% in the second quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock valued at $157,000 after purchasing an additional 101 shares during the last quarter. GW Henssler & Associates Ltd. acquired a new stake in Maximus in the second quarter valued at $205,000. Finally, Comerica Securities Inc. grew its holdings in Maximus by 5.9% in the second quarter. Comerica Securities Inc. now owns 4,002 shares of the health services provider’s stock valued at $251,000 after purchasing an additional 223 shares during the last quarter. 97.23% of the stock is currently owned by institutional investors.
Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million during the quarter, compared to the consensus estimate of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same period last year, the business posted $0.79 earnings per share.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $0.18 annualized dividend and a yield of 0.28%. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
ILLEGAL ACTIVITY NOTICE: “Maximus, Inc. (NYSE:MMS) Holdings Raised by Janus Henderson Group PLC” was first posted by BBNS and is owned by of BBNS. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/janus-henderson-group-plc-has-138-52-million-holdings-in-maximus-inc-mms/1701849.html.
In other news, President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $60.97, for a total value of $487,760.00. Following the completion of the sale, the president now directly owns 35,904 shares in the company, valued at $2,189,066.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, General Counsel David Francis sold 2,000 shares of Maximus stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $58.89, for a total transaction of $117,780.00. Following the completion of the sale, the general counsel now owns 13,716 shares of the company’s stock, valued at $807,735.24. The disclosure for this sale can be found here. Insiders have sold 151,403 shares of company stock valued at $9,354,041 over the last 90 days. Company insiders own 3.10% of the company’s stock.
MMS has been the topic of a number of analyst reports. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Robert W. Baird reaffirmed a “hold” rating and set a $64.00 price objective on shares of Maximus in a research note on Friday, September 1st. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research note on Tuesday, July 4th. Maxim Group set a $66.00 target price on Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Finally, BidaskClub downgraded Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. One research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the stock. The company currently has an average rating of “Hold” and an average target price of $63.14.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with our FREE daily email newsletter.